Perigon Wealth Management LLC Grows Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Perigon Wealth Management LLC grew its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,160 shares of the company’s stock after purchasing an additional 293 shares during the quarter. Perigon Wealth Management LLC’s holdings in GE HealthCare Technologies were worth $554,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in GEHC. First Command Advisory Services Inc. increased its holdings in shares of GE HealthCare Technologies by 36,900.0% in the 3rd quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after acquiring an additional 369 shares during the period. Pin Oak Investment Advisors Inc. bought a new stake in shares of GE HealthCare Technologies in the 2nd quarter valued at about $25,000. Householder Group Estate & Retirement Specialist LLC purchased a new position in shares of GE HealthCare Technologies in the 3rd quarter worth approximately $26,000. Legacy Financial Group LLC bought a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Finally, OFI Invest Asset Management purchased a new stake in GE HealthCare Technologies during the third quarter valued at approximately $26,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Down 0.2 %

GE HealthCare Technologies stock opened at $86.13 on Tuesday. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18. The firm has a market cap of $39.30 billion, a PE ratio of 28.52, a P/E/G ratio of 3.00 and a beta of 0.95. The stock’s 50 day simple moving average is $88.47 and its two-hundred day simple moving average is $77.47. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.07 by $0.11. The company had revenue of $5.20 billion for the quarter, compared to analyst estimates of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The firm’s revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the business earned $1.31 earnings per share. Analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a dividend of $0.03 per share. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is currently 3.97%.

Analyst Upgrades and Downgrades

Several analysts have recently commented on GEHC shares. Evercore ISI increased their price objective on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a report on Thursday, April 4th. HSBC assumed coverage on GE HealthCare Technologies in a research note on Thursday, February 15th. They set a “buy” rating and a $100.00 price target on the stock. Citigroup lifted their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Mizuho upped their price target on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, April 11th. Finally, UBS Group upgraded shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lifted their price objective for the stock from $66.00 to $88.00 in a research note on Monday, February 12th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $95.08.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.